The International Sepsis Forum (ISF) is a unique collaborative effort between industry and academia. It is the first initiative to focus solely on management of patients with severe sepsis.

While sepsis and its sequelae are still associated with high rates of morbidity and mortality, new data on patient management are emerging that may ultimately improve the current situation. Such findings need to be evaluated and incorporated, when appropriate, into existing treatment protocols. Dr. Uttenthal’s presentation on APC-PCI is controversial and innovative and BioPorto Diagnostics expects these findings to arouse considerable interest from both industry and academia.